Concepedia

Linkang Cai

LC

Statistics

Publications

3

Citations

76

H-Index

3

Active since

2020

Affiliations

Hubei University of Technology(Current)

Wuhan YZY Biopharma (China)

Hubei Cancer Hospital

Linkang Cai is an author at Hubei University of Technology specializing in oncolytic virus therapy, oncolytic viral vectors, and oncology.

ORCID

Publications per year

2020–2022

3

Publications

3

A novel cocktail therapy based on quintuplet combination of oncolytic herpes simplex virus-2 vectors armed with interleukin-12, interleukin-15, GM-CSF, PD1v, and IL-7 × CCL19 results in enhanced antitumor efficacy

Han Hu, Siqi Zhang, Linkang Cai et al. · Virology Journal · 2022 · 38 citations · Full text

, , +15

The construction of a new oncolytic herpes simplex virus expressing murine interleukin‐15 with gene‐editing technology

Linkang Cai, Han Hu, Haixiao Duan et al. · Journal of Medical Virology · 2020 · 22 citations

, , +17

Bispecific Antibody Expressed by an Oncolytic Herpes Simplex Virus Type 2 Can Transform Heterologous T Cells Into Uniform Tumor Killer Cells

Jing Jin, Runyang Wang, Junhan Yang et al. · Human Gene Therapy · 2022 · 16 citations · Full text

, , +17

1–3 of 3